The functions and regulation of the PTEN tumour suppressor (original) (raw)

• Bigner, S. H., Mark, J., Mahaley, M. S. & Bigner, D. D. Patterns of the early, gross chromosomal changes in malignant human gliomas. Hereditas 101, 103–113 (1984).
  Article CAS PubMed Google Scholar
• Li, J. et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943–1947 (1997).
  Article CAS PubMed Google Scholar
• Steck, P. A. et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature Genet. 15, 356–362 (1997).
  Article CAS PubMed Google Scholar
• Di Cristofano, A., Pesce, B., Cordon-Cardo, C. & Pandolfi, P. P. Pten is essential for embryonic development and tumour suppression. Nature Genet. 19, 348–355 (1998).
  Article CAS PubMed Google Scholar
• Suzuki, A. et al. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr. Biol. 8, 1169–1178 (1998).
  Article CAS PubMed Google Scholar
• Podsypanina, K. et al. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc. Natl Acad. Sci. USA 96, 1563–1568 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Di Cristofano, A., De Acetis, M., Koff, A., Cordon-Cardo, C. & Pandolfi, P. P. Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse. Nature Genet. 27, 222–224 (2001).
  Article CAS PubMed Google Scholar
• Di Cristofano, A. et al. Impaired Fas response and autoimmunity in Pten +/− mice. Science 285, 2122–2125 (1999).
  Article CAS PubMed Google Scholar
• Alimonti, A. et al. Subtle variations in Pten dose determine cancer susceptibility. Nature Genet. 42, 454–458 (2010).
  Article CAS PubMed Google Scholar
• Berger, A. H., Knudson, A. G. & Pandolfi, P. P. A continuum model for tumour suppression. Nature 476, 163–169 (2011). References 9 and 10 demonstrate the crucial role of PTEN as a haploinsufficient tumour suppressor gene and propose a continuum model for tumour suppression.
  Article CAS PubMed PubMed Central Google Scholar
• Knudson, A. G. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl Acad. Sci. USA 68, 820–823 (1971).
  Article PubMed PubMed Central Google Scholar
• Maehama, T. & Dixon, J. E. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 273, 13375–13378 (1998).
  Article CAS PubMed Google Scholar
• Stambolic, V. et al. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95, 29–39 (1998).
  Article CAS PubMed Google Scholar
• Sun, H. et al. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5-trisphosphate and Akt/protein kinase B signaling pathway. Proc. Natl Acad. Sci. USA 96, 6199–6204 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Denu, J. M., Stuckey, J. A., Saper, M. A. & Dixon, J. E. Form and function in protein dephosphorylation. Cell 87, 361–364 (1996).
  Article CAS PubMed Google Scholar
• Myers, M. P. et al. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc. Natl Acad. Sci. USA 94, 9052–9057 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Lee, J. O. et al. Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell 99, 323–334 (1999).
  Article CAS PubMed Google Scholar
• Raftopoulou, M., Etienne-Manneville, S., Self, A., Nicholls, S. & Hall, A. Regulation of cell migration by the C2 domain of the tumor suppressor PTEN. Science 303, 1179–1181 (2004).
  Article CAS PubMed Google Scholar
• Manning, B. D. & Cantley, L. C. AKT/PKB signaling: navigating downstream. Cell 129, 1261–1274 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Zoncu, R., Efeyan, A. & Sabatini, D. M. mTOR: from growth signal integration to cancer, diabetes and ageing. Nature Rev. Mol. Cell Biol. 12, 21–35 (2011).
  Article CAS Google Scholar
• Guertin, D. A. & Sabatini, D. M. Defining the role of mTOR in cancer. Cancer Cell 12, 9–22 (2007).
  Article CAS PubMed Google Scholar
• Vander Haar, E., Lee, S. I., Bandhakavi, S., Griffin, T. J. & Kim, D. H. Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40. Nature Cell Biol. 9, 316–323 (2007).
  Article CAS PubMed Google Scholar
• Ma, X. M. & Blenis, J. Molecular mechanisms of mTOR-mediated translational control. Nature Rev. Mol. Cell Biol. 10, 307–318 (2009).
  Article CAS Google Scholar
• Dowling, R. J. et al. mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs. Science 328, 1172–1176 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Hsieh, A. C. et al. Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP–eIF4E. Cancer Cell 17, 249–261 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• She, Q. B. et al. 4E-BP1 is a key effector of the oncogenic activation of the AKT and ERK signaling pathways that integrates their function in tumors. Cancer Cell 18, 39–51 (2010). References 24, 25 and 26 describe a key role for 4EBP1-mediated translational control in the proliferation and survival of cancer cells.
  Article CAS PubMed PubMed Central Google Scholar
• Radimerski, T., Montagne, J., Hemmings-Mieszczak, M. & Thomas, G. Lethality of Drosophila lacking TSC tumor suppressor function rescued by reducing dS6K signaling. Genes Dev. 16, 2627–2632 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, H. et al. Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J. Clin. Invest. 112, 1223–1233 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Harrington, L. S. et al. The TSC1–2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins. J. Cell Biol. 166, 213–223 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Um, S. H. et al. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 431, 200–205 (2004).
  Article CAS PubMed Google Scholar
• Carracedo, A. et al. Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer. J. Clin. Invest. 118, 3065–3074 (2008).
  CAS PubMed PubMed Central Google Scholar
• Kinkade, C. W. et al. Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model. J. Clin. Invest. 118, 3051–3064 (2008). References 31 and 32 provide evidence that mTORC1 inhibitors result in increased activation of the RAS–MAPK pathway through a PI3K-dependent feedback loop.
  CAS PubMed PubMed Central Google Scholar
• Wan, X., Harkavy, B., Shen, N., Grohar, P. & Helman, L. J. Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism. Oncogene 26, 1932–1940 (2007).
  Article CAS PubMed Google Scholar
• Tamburini, J. et al. Mammalian target of rapamycin (mTOR) inhibition activates phosphatidylinositol 3-kinase/Akt by up-regulating insulin-like growth factor-1 receptor signaling in acute myeloid leukemia: rationale for therapeutic inhibition of both pathways. Blood 111, 379–382 (2008).
  Article CAS PubMed Google Scholar
• Hsu, P. P. et al. The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 332, 1317–1322 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Yu, Y. et al. Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Science 332, 1322–1326 (2011). References 35 and 36 report GRB10 as an mTORC1 substrate and an effector of the mTORC1–PI3K feedback loop.
  Article CAS PubMed PubMed Central Google Scholar
• Manning, B. D. et al. Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2. Genes Dev. 19, 1773–1778 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Nardella, C. et al. Aberrant Rheb-mediated mTORC1 activation and Pten haploinsufficiency are cooperative oncogenic events. Genes Dev. 22, 2172–2177 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Salmena, L., Carracedo, A. & Pandolfi, P. P. Tenets of PTEN tumor suppression. Cell 133, 403–414 (2008).
  Article CAS PubMed Google Scholar
• Warburg, O. On respiratory impairment in cancer cells. Science 124, 269–270 (1956).
  Article CAS PubMed Google Scholar
• Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029–1033 (2009). This review comprehensively discusses the links between cell metabolism and cancer.
  Article CAS PubMed PubMed Central Google Scholar
• Eguez, L. et al. Full intracellular retention of GLUT4 requires AS160 Rab GTPase activating protein. Cell Metab. 2, 263–272 (2005).
  Article CAS PubMed Google Scholar
• Sundqvist, A. et al. Control of lipid metabolism by phosphorylation-dependent degradation of the SREBP family of transcription factors by SCF(Fbw7). Cell Metab. 1, 379–391 (2005).
  Article CAS PubMed Google Scholar
• Li, X., Monks, B., Ge, Q. & Birnbaum, M. J. Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1α transcription coactivator. Nature 447, 1012–1016 (2007).
  Article CAS PubMed Google Scholar
• Horie, Y. et al. Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas. J. Clin. Invest. 113, 1774–1783 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Fang, M. et al. The ER UDPase ENTPD5 promotes protein _N_-glycosylation, the Warburg effect, and proliferation in the PTEN pathway. Cell 143, 711–724 (2010).
  Article CAS PubMed Google Scholar
• Kalaany, N. Y. & Sabatini, D. M. Tumours with PI3K activation are resistant to dietary restriction. Nature 458, 725–731 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Liliental, J. et al. Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases. Curr. Biol. 10, 401–404 (2000).
  Article CAS PubMed Google Scholar
• Tamura, M. et al. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280, 1614–1617 (1998).
  Article CAS PubMed Google Scholar
• Martin-Belmonte, F. et al. PTEN-mediated apical segregation of phosphoinositides controls epithelial morphogenesis through Cdc42. Cell 128, 383–397 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Song, L. B. et al. The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. J. Clin. Invest. 119, 3626–3636 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Trimboli, A. J. et al. Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature 461, 1084–1091 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Kalluri, R. & Zeisberg, M. Fibroblasts in cancer. Nature Rev. Cancer 6, 392–401 (2006).
  Article CAS Google Scholar
• Bronisz, A. et al. Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320. Nature Cell Biol. 14, 159–167 (2012). References 52 and 54 demonstrate a key role of PTEN in shaping the tumour microenvironment.
  Article CAS Google Scholar
• Kurose, K. et al. Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nature Genet. 32, 355–357 (2002).
  Article CAS PubMed Google Scholar
• Hu, M. et al. Distinct epigenetic changes in the stromal cells of breast cancers. Nature Genet. 37, 899–905 (2005).
  Article CAS PubMed Google Scholar
• Lin, H. K. et al. Skp2 targeting suppresses tumorigenesis by Arf–p53-independent cellular senescence. Nature 464, 374–379 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Alimonti, A. et al. A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis. J. Clin. Invest. 120, 681–693 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Chen, Z. et al. Crucial role of p53-dependent cellular senescence in suppression of _Pten_-deficient tumorigenesis. Nature 436, 725–730 (2005). References 58 and 59 provide evidence that p53-mediated cellular senescence suppresses PTEN -deficient tumorigenesis.
  Article CAS PubMed PubMed Central Google Scholar
• Nardella, C. et al. Differential requirement of mTOR in postmitotic tissues and tumorigenesis. Sci. Signal. 2, ra2 (2009).
  Article PubMed PubMed Central CAS Google Scholar
• Chen, Z. et al. Differential p53-independent outcomes of p19(Arf) loss in oncogenesis. Sci. Signal. 2, ra44 (2009).
  PubMed PubMed Central Google Scholar
• Palmero, I., Pantoja, C. & Serrano, M. p19ARF links the tumour suppressor p53 to Ras. Nature 395, 125–126 (1998).
  Article CAS PubMed Google Scholar
• Ohtani, N. et al. Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature 409, 1067–1070 (2001).
  Article CAS PubMed Google Scholar
• Song, M. S. et al. Nuclear PTEN regulates the APC–CDH1 tumor-suppressive complex in a phosphatase-independent manner. Cell 144, 187–199 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Li, M. et al. The adaptor protein of the anaphase promoting complex Cdh1 is essential in maintaining replicative lifespan and in learning and memory. Nature Cell Biol. 10, 1083–1089 (2008).
  Article CAS PubMed Google Scholar
• Ding, Z. et al. SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression. Nature 470, 269–273 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Nardella, C., Clohessy, J. G., Alimonti, A. & Pandolfi, P. P. Pro-senescence therapy for cancer treatment. Nature Rev. Cancer 11, 503–511 (2011).
  Article CAS Google Scholar
• Groszer, M. et al. Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo. Science 294, 2186–2189 (2001).
  Article CAS PubMed Google Scholar
• Bonaguidi, M. A. et al. In vivo clonal analysis reveals self-renewing and multipotent adult neural stem cell characteristics. Cell 145, 1142–1155 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, J. et al. PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention. Nature 441, 518–522 (2006).
  Article CAS PubMed Google Scholar
• Yilmaz, O. H. et al. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 441, 475–482 (2006).
  Article CAS PubMed Google Scholar
• Ito, K., Bernardi, R. & Pandolfi, P. P. A novel signaling network as a critical rheostat for the biology and maintenance of the normal stem cell and the cancer-initiating cell. Curr. Opin. Genet. Dev. 19, 51–59 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Lee, J. Y. et al. mTOR activation induces tumor suppressors that inhibit leukemogenesis and deplete hematopoietic stem cells after Pten deletion. Cell Stem Cell 7, 593–605 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Guo, W. et al. Multi-genetic events collaboratively contribute to _Pten_-null leukaemia stem-cell formation. Nature 453, 529–533 (2008). References 70–74 demonstrate the crucial role of PTEN for cancer stem cell formation and haematopoietic stem cell homeostasis.
  Article CAS PubMed PubMed Central Google Scholar
• Lindsay, Y. et al. Localization of agonist-sensitive PtdIns(3,4,5)P3 reveals a nuclear pool that is insensitive to PTEN expression. J. Cell Sci. 119, 5160–5168 (2006).
  Article CAS PubMed Google Scholar
• Shen, W. H. et al. Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell 128, 157–170 (2007). References 64 and 76 identify novel tumour suppressive functions of nuclear PTEN in its phosphatase-independent mode.
  Article CAS PubMed Google Scholar
• Puc, J. et al. Lack of PTEN sequesters CHK1 and initiates genetic instability. Cancer Cell 7, 193–204 (2005).
  Article CAS PubMed Google Scholar
• Mendes-Pereira, A. M. et al. Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors. EMBO Mol. Med. 1, 315–322 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• McEllin, B. et al. PTEN loss compromises homologous recombination repair in astrocytes: implications for glioblastoma therapy with temozolomide or poly(ADP-ribose) polymerase inhibitors. Cancer Res. 70, 5457–5464 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Dedes, K. J. et al. PTEN deficiency in endometrioid endometrial adenocarcinomas predicts sensitivity to PARP inhibitors. Sci. Transl. Med. 2, 53ra75 (2010).
  Article PubMed CAS Google Scholar
• Liu, X. S. et al. Polo-like kinase 1 facilitates loss of Pten tumor suppressor-induced prostate cancer formation. J. Biol. Chem. 286, 35795–35800 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Blanco-Aparicio, C., Renner, O., Leal, J. F. & Carnero, A. PTEN, more than the AKT pathway. Carcinogenesis 28, 1379–1386 (2007).
  Article CAS PubMed Google Scholar
• Kharas, M. G. et al. Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in mice. Blood 115, 1406–1415 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Vivanco, I. et al. Identification of the JNK signaling pathway as a functional target of the tumor suppressor PTEN. Cancer Cell 11, 555–569 (2007).
  Article CAS PubMed Google Scholar
• Okumura, K., Zhao, M., Depinho, R. A., Furnari, F. B. & Cavenee, W. K. Cellular transformation by the MSP58 oncogene is inhibited by its physical interaction with the PTEN tumor suppressor. Proc. Natl Acad. Sci. USA 102, 2703–2706 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Mounir, Z. et al. Tumor suppression by PTEN requires the activation of the PKR–eIF2α phosphorylation pathway. Sci. Signal. 2, ra85 (2009).
  PubMed PubMed Central Google Scholar
• Gu, T. et al. CREB is a novel nuclear target of PTEN phosphatase. Cancer Res. 71, 2821–2825 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, S. et al. Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways. Nature Med. 17, 461–469 (2011).
  Article PubMed CAS Google Scholar
• Hollander, M. C., Blumenthal, G. M. & Dennis, P. A. PTEN loss in the continuum of common cancers, rare syndromes and mouse models. Nature Rev. Cancer 11, 289–301 (2011).
  Article CAS Google Scholar
• Eng, C. PTEN: one gene, many syndromes. Hum. Mutat. 22, 183–198 (2003).
  Article CAS PubMed Google Scholar
• Trotman, L. C. et al. Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell 128, 141–156 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Zhou, X. P. et al. Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway. Am. J. Hum. Genet. 73, 404–411 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Lu, J. et al. Stem cell factor SALL4 represses the transcriptions of PTEN and SALL1 through an epigenetic repressor complex. PLoS ONE 4, e5577 (2009).
  Article PubMed PubMed Central CAS Google Scholar
• Agrawal, S. & Eng, C. Differential expression of novel naturally occurring splice variants of PTEN and their functional consequences in Cowden syndrome and sporadic breast cancer. Hum. Mol. Genet. 15, 777–787 (2006).
  Article CAS PubMed Google Scholar
• Escriva, M. et al. Repression of PTEN phosphatase by Snail1 transcriptional factor during γ-radiation-induced apoptosis. Mol. Cell. Biol. 28, 1528–1540 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Lee, J. Y. et al. Id-1 activates Akt-mediated Wnt signaling and p27(Kip1) phosphorylation through PTEN inhibition. Oncogene 28, 824–831 (2009).
  Article CAS PubMed Google Scholar
• Stambolic, V. et al. Regulation of PTEN transcription by p53. Mol. Cell 8, 317–325 (2001).
  Article CAS PubMed Google Scholar
• Yoshimi, A. et al. Evi1 represses PTEN expression and activates PI3K/AKT/mTOR via interactions with polycomb proteins. Blood 117, 3617–3628 (2011).
  Article CAS PubMed Google Scholar
• Whelan, J. T., Forbes, S. L. & Bertrand, F. E. CBF-1 (RBP-Jκ) binds to the PTEN promoter and regulates PTEN gene expression. Cell Cycle 6, 80–84 (2007).
  Article CAS PubMed Google Scholar
• Hettinger, K. et al. c-Jun promotes cellular survival by suppression of PTEN. Cell Death Differ. 14, 218–229 (2007).
  Article CAS PubMed Google Scholar
• Xia, D. et al. Mitogen-activated protein kinase kinase-4 promotes cell survival by decreasing PTEN expression through an NF-κB-dependent pathway. J. Biol. Chem. 282, 3507–3519 (2007).
  Article CAS PubMed Google Scholar
• Patel, L. et al. Tumor suppressor and anti-inflammatory actions of PPARγ agonists are mediated via upregulation of PTEN. Curr. Biol. 11, 764–768 (2001).
  Article CAS PubMed Google Scholar
• Virolle, T. et al. The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling. Nature Cell Biol. 3, 1124–1128 (2001).
  Article CAS PubMed Google Scholar
• Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215–233 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Xiao, C. et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17–92 expression in lymphocytes. Nature Immunol. 9, 405–414 (2008).
  Article CAS Google Scholar
• Olive, V. et al. miR-19 is a key oncogenic component of mir-17-92. Genes Dev. 23, 2839–2849 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Mavrakis, K. J. et al. Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia. Nature Cell Biol. 12, 372–379 (2010). References 105, 106 and107 identify oncogenic miR-19 as PTEN-targeting for tumorigenesis.
  Article CAS PubMed Google Scholar
• Meng, F. et al. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133, 647–658 (2007).
  Article CAS PubMed Google Scholar
• Ma, X. et al. Loss of the miR-21 allele elevates the expression of its target genes and reduces tumorigenesis. Proc. Natl Acad. Sci. USA 108, 10144–10149 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Mu, P. et al. Genetic dissection of the miR-17∼92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev. 23, 2806–2811 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Poliseno, L. et al. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 465, 1033–1038 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Salmena, L., Poliseno, L., Tay, Y., Kats, L. & Pandolfi, P. P. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 146, 353–358 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Karreth, F. A. et al. In vivo identification of tumor-suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma. Cell 147, 382–395 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Sumazin, P. et al. An extensive microRNA-mediated network of RNA–RNA interactions regulates established oncogenic pathways in glioblastoma. Cell 147, 370–381 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Tay, Y. et al. Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell 147, 344–357 (2011). References 111–115 provide evidence that RNA transcripts communicate through a new 'language' mediated by miRNA-binding sites.
  Article CAS PubMed PubMed Central Google Scholar
• Rabinovsky, R. et al. p85 associates with unphosphorylated PTEN and the PTEN-associated complex. Mol. Cell. Biol. 29, 5377–5388 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Vazquez, F. et al. Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex. J. Biol. Chem. 276, 48627–48630 (2001).
  Article CAS PubMed Google Scholar
• Liang, K. et al. Recombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivation. Cancer Cell 18, 423–435 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Al-Khouri, A. M., Ma, Y., Togo, S. H., Williams, S. & Mustelin, T. Cooperative phosphorylation of the tumor suppressor phosphatase and tensin homologue (PTEN) by casein kinases and glycogen synthase kinase 3β. J. Biol. Chem. 280, 35195–35202 (2005).
  Article CAS PubMed Google Scholar
• Xu, D., Yao, Y., Jiang, X., Lu, L. & Dai, W. Regulation of PTEN stability and activity by Plk3. J. Biol. Chem. 285, 39935–39942 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Li, Z. et al. Regulation of PTEN by Rho small GTPases. Nature Cell Biol. 7, 399–404 (2005).
  Article CAS PubMed Google Scholar
• Yim, E. K. et al. Rak functions as a tumor suppressor by regulating PTEN protein stability and function. Cancer Cell 15, 304–314 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, X. et al. NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN. Cell 128, 129–139 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Okumura, K. et al. PCAF modulates PTEN activity. J. Biol. Chem. 281, 26562–26568 (2006).
  Article CAS PubMed Google Scholar
• Chae, H. D. & Broxmeyer, H. E. SIRT1 deficiency downregulates PTEN/JNK/FOXO1 pathway to block reactive oxygen species-induced apoptosis in mouse embryonic stem cells. Stem Cells Dev. 20, 1277–1285 (2011).
  Article CAS PubMed Google Scholar
• Lee, S. R. et al. Reversible inactivation of the tumor suppressor PTEN by H2O2 . J. Biol. Chem. 277, 20336–20342 (2002).
  Article CAS PubMed Google Scholar
• Silva, A. et al. PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability. J. Clin. Invest. 118, 3762–3774 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Hui, S. T. et al. Txnip balances metabolic and growth signaling via PTEN disulfide reduction. Proc. Natl Acad. Sci. USA 105, 3921–3926 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Cao, J. et al. Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity. EMBO J. 28, 1505–1517 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Drinjakovic, J. et al. E3 ligase Nedd4 promotes axon branching by downregulating PTEN. Neuron 65, 341–357 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Fouladkou, F. et al. The ubiquitin ligase Nedd4-1 is dispensable for the regulation of PTEN stability and localization. Proc. Natl Acad. Sci. USA 105, 8585–8590 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Van Themsche, C., Leblanc, V., Parent, S. & Asselin, E. X-linked inhibitor of apoptosis protein (XIAP) regulates PTEN ubiquitination, content, and compartmentalization. J. Biol. Chem. 284, 20462–20466 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Maddika, S. et al. WWP2 is an E3 ubiquitin ligase for PTEN. Nature Cell Biol. 13, 728–733 (2011).
  Article PubMed CAS Google Scholar
• Gunaratne, J. et al. Protein interactions of phosphatase and tensin homologue (PTEN) and its cancer-associated G20E mutant compared by using stable isotope labeling by amino acids in cell culture-based parallel affinity purification. J. Biol. Chem. 286, 18093–18103 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Song, M. S. et al. The deubiquitinylation and localization of PTEN are regulated by a HAUSP–PML network. Nature 455, 813–817 (2008). References 91, 123 and 135 provide evidence that PTEN is modified by an ubiquitylation–deubiquitylation network.
  Article CAS PubMed PubMed Central Google Scholar
• Takahashi, Y., Morales, F. C., Kreimann, E. L. & Georgescu, M. M. PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling. EMBO J. 25, 910–920 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Molina, J. R. et al. PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma. Oncogene 31, 1264–1274 (2012).
  Article CAS PubMed Google Scholar
• Lima-Fernandes, E. et al. Distinct functional outputs of PTEN signalling are controlled by dynamic association with β-arrestins. EMBO J. 30, 2557–2568 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Wu, X. et al. Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2. Proc. Natl Acad. Sci. USA 97, 4233–4238 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• van Diepen, M. T. et al. MyosinV controls PTEN function and neuronal cell size. Nature Cell Biol. 11, 1191–1196 (2009).
  Article CAS PubMed Google Scholar
• Cotter, L. et al. Dlg1–PTEN interaction regulates myelin thickness to prevent damaging peripheral nerve overmyelination. Science 328, 1415–1418 (2010).
  Article CAS PubMed Google Scholar
• Chagpar, R. B. et al. Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase. Proc. Natl Acad. Sci. USA 107, 5471–5476 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Taniguchi, C. M. et al. The phosphoinositide 3-kinase regulatory subunit p85α can exert tumor suppressor properties through negative regulation of growth factor signaling. Cancer Res. 70, 5305–5315 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Kim, R. H. et al. DJ-1, a novel regulator of the tumor suppressor PTEN. Cancer Cell 7, 263–273 (2005).
  Article CAS PubMed Google Scholar
• Kim, Y. C., Kitaura, H., Taira, T., Iguchi-Ariga, S. M. & Ariga, H. Oxidation of DJ-1-dependent cell transformation through direct binding of DJ-1 to PTEN. Int. J. Oncol. 35, 1331–1341 (2009).
  CAS PubMed Google Scholar
• Fine, B. et al. Activation of the PI3K pathway in cancer through inhibition of PTEN by exchange factor P-REX2a. Science 325, 1261–1265 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• He, L., Ingram, A., Rybak, A. P. & Tang, D. Shank-interacting protein-like 1 promotes tumorigenesis via PTEN inhibition in human tumor cells. J. Clin. Invest. 120, 2094–2108 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• He, L. et al. α-mannosidase 2C1 attenuates PTEN function in prostate cancer cells. Nature Commun. 2, 307 (2011).
  Article CAS Google Scholar
• Engelman, J. A., Luo, J. & Cantley, L. C. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nature Rev. Genet. 7, 606–619 (2006).
  Article CAS PubMed Google Scholar
• Vanhaesebroeck, B., Guillermet-Guibert, J., Graupera, M. & Bilanges, B. The emerging mechanisms of isoform-specific PI3K signalling. Nature Rev. Mol. Cell Biol. 11, 329–341 (2010).
  Article CAS Google Scholar
• Juhasz, G. et al. The class III PI(3)K Vps34 promotes autophagy and endocytosis but not TOR signaling in Drosophila. J. Cell Biol. 181, 655–666 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Scheid, M. P. & Woodgett, J. R. PKB/AKT: functional insights from genetic models. Nature Rev. Mol. Cell Biol. 2, 760–768 (2001).
  Article CAS Google Scholar
• Liaw, D. et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nature Genet. 16, 64–67 (1997).
  Article CAS PubMed Google Scholar
• Backman, S. A. et al. Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease. Nature Genet. 29, 396–403 (2001).
  Article CAS PubMed Google Scholar
• Kwon, C. H. et al. Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease. Nature Genet. 29, 404–411 (2001).
  Article CAS PubMed Google Scholar
• Meng, F. et al. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 130, 2113–2129 (2006).
  Article CAS PubMed Google Scholar
• Carver, B. S. et al. Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate. Nature Genet. 41, 619–624 (2009).
  Article CAS PubMed Google Scholar
• King, J. C. et al. Cooperativity of TMPRSS2–ERG with PI3-kinase pathway activation in prostate oncogenesis. Nature Genet. 41, 524–526 (2009). References 157 and 158 provide evidence that ERG (v-ets erythroblastosis virus E26 oncogene homologue) cooperates with PTEN to promote cancer progression.
  Article CAS PubMed Google Scholar
• Okahara, F., Ikawa, H., Kanaho, Y. & Maehama, T. Regulation of PTEN phosphorylation and stability by a tumor suppressor candidate protein. J. Biol. Chem. 279, 45300–45303 (2004).
  Article CAS PubMed Google Scholar